Login / Signup

Considerations for the Role of the Pharmacist in Managing Patients on Eculizumab for Hematopoietic Stem Cell Transplantation-Related Thrombotic Microangiopathy.

Ariel DensonMargaret Croom TaylorJustin R Arnall
Published in: The Annals of pharmacotherapy (2022)
Keyphrases
  • end stage renal disease
  • newly diagnosed
  • ejection fraction
  • chronic kidney disease
  • acute myeloid leukemia
  • peritoneal dialysis
  • prognostic factors
  • drug induced